Study of the Glymphatic System in Migraine
Key facts
- Where
- Milan, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Source: NCT05907655, who can take part
Where in Italy
- IRCCS San Raffaele HospitalMilan, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IRCCS San Raffaele
- Trial code
- NCT05907655
- Record updated
- 6 November 2026
- Original description
This study aimed to investigate the role of the glymphatic system in the initiation of migraine attacks, using non-invasive magnetic resonance imaging techniques and a validated model of migraine induction by nitroglycerin administration. Secondarily, the relationship between the function of the glymphatic system during nitroglycerin-induced migraine attacks and sleep architecture and plasma levels of migraine-involved neuropeptides will be investigated.Read full original descriptionShow less
Discovering the Functional Role of the Glymphatic System in the Genesis of the Migraine Attack
This study aimed to investigate the role of the glymphatic system in the initiation of migraine attacks, using non-invasive magnetic resonance imaging techniques and a validated model of migraine induction by nitroglycerin administration. Secondarily, the relationship between the function of the glymphatic system during nitroglycerin-induced migraine attacks and sleep architecture and plasma levels of migraine-involved neuropeptides will be investigated.
Inclusion: For patients:; Diagnosis of migraine, by the ICHD-3 criteria; For both patients and healthy controls:; Age between 18 and 60 years; Willing and able to comply with scheduled visits.
Exclusion: Overuse of acute medications for headache; Any person where MRI scanning is contraindicated (metal implants, pacemaker, claustrophobia, etc.); Use of illicit drugs; Other primary headache disorders, with the exception of infrequent tension-type headache; For healthy controls:; Any subject with frequent tension type headache, migraine, cluster headache, other pain syndromes or neurological conditions; For both patients and healthy controls:; Allergy to nitroglycerin; Major psychiatric disorders such as bipolar affective disorder and schizophrenia; Cardiovascular diseases that contraindicated the use of nitroglycerin; Intracranial hypertension; Cerebral haemorrhage; For patients:; Continuous or daily headache; Cerebral trauma; Pulmonary toxic oedema; Closed angle glaucoma; Anaemia; Pregnancy and breastfeeding; Aortic stenosis or significant hypotension (SBP<90mmHg or <100mmHg and symptomatic) precluding nitroglycerin administration; Use of sildenafil; Any person unable to lie still within the environment of the MRI scanner for the required period to perform the study; MRI head showing any brain pathology, such as space-occupying lesions; Any person unable to understand and follow the instructions of the investigators.